A year in review – Reflecting on 2023
As we come closer to the end of the year, I want to take the opportunity to reflect on 2023 and all that we have
December 29, 2023
Menu
As we come closer to the end of the year, I want to take the opportunity to reflect on 2023 and all that we have
At MAC, we consistently prioritise subject diversity in the trials we run and manage. We highly value this commitment and, by leveraging our distinctive grasp
With insight from Dr Abiramy Yogendran Menopause is a natural biological process that marks the end of a woman’s reproductive years and typically occurs, when
Last week we attended the PHUSE EU Connect 2023 conference in Birmingham from 5 to 8 November. The conference was an excellent opportunity to connect
At the beginning of November, our Vice President of Global Proposals, Jude Warburton attended AusBiotech 2023 in Brisbane, Australia. This conference is Australia’s largest Life
Kariya Pharmaceuticals has received approval from the MHRA for their Clinical Trial Application (CTA) related to their leading Parkinson’s drug program, KP405. KP405 is a
Alzheimer’s Disease (AD) is a complex and pervasive condition that affects the central nervous system (CNS) of millions of lives worldwide. Currently around 50 million
Psoriasis is a chronic skin disease that affects millions of people worldwide causing uncomfortable and itchy scaly patches primarily on the knees, elbows, and scalp.
Did you know we provide an array of scientific solutions for our sponsors? One of these bespoke and highly interesting offerings is Human Experimental Models
Social connections are vital for our health and wellbeing. With the advent of the internet, smartphones, and social media, it’s possible to speak to someone